Results 1 to 10 of about 2,246,897 (273)

Macrolide Resistance in Streptococcus pneumoniae [PDF]

Frontiers in Cellular and Infection Microbiology, 2016
Streptococcus pneumoniae is a common commensal and an opportunistic pathogen. Suspected pneumococcal upper respiratory infections and pneumonia are often treated with macrolide antibiotics.
Max R Schroeder, David S. Stephens, David S. Stephens, David S. Stephens   +3 more
doaj   +4 more sources

Macrolide resistance due to erm(55) [PDF]

Microbiology Spectrum
Antimicrobial resistance (AMR) is a global threat. The identification and characterization of novel resistance genes is integral to AMR surveillance.
David C. Alexander, Tayah Farquhar, Joshua M. E. Adams, Danae M. Suchan, Sean D. Workman, Richard J. Wallace Jr., Barbara A. Brown-Elliott, Omar M. El-Halfawy, Andrew D. S. Cameron   +8 more
doaj   +3 more sources

Macrolide resistance in Mycoplasma pneumoniae in adult patients [PDF]

Frontiers in Cellular and Infection Microbiology
Mycoplasma pneumoniae is one of the most significant pathogens responsible for respiratory infections in humans. Macrolides are recommended as the first-line treatment for M. pneumoniae infection. The prevalence of macrolide-resistant M.
Panpan Xie, Panpan Xie, Yue Zhang, Yue Zhang, Yanhong Qin, Yanhong Qin, Yun Fang, Yun Fang, Ning Yang, Ning Yang, Yunbiao Bai, Yunbiao Bai, Shimeng Zhi, Shimeng Zhi, Wenkai Niu, Wenkai Niu, Fusheng Wang, Xin Yuan, Xin Yuan, Xin Yuan   +19 more
doaj   +4 more sources

Persistent high macrolide resistance rate and increase of macrolide-resistant ST14 strains among Mycoplasma pneumoniae in South Korea, 2019–2020

Journal of Microbiology, Immunology and Infection, 2022
Background: Expansion of the single sequence type 3 (ST3) was associated with a high macrolide resistance rate among Mycoplasma pneumoniae in Korea during the 2014–2016 epidemic. This study investigates the macrolide resistance rate and genetic diversity
Joon Kee Lee, Youn Young Choi, Young Joo Sohn, Kyung-Min Kim, Ye Kyung Kim, Mi Seon Han, Ji Young Park, Eun Young Cho, Jae Hong Choi, Eun Hwa Choi   +9 more
doaj   +2 more sources

Clinical performance of two commercial PCR assays for the detection of macrolide resistance in Mycoplasma pneumoniae [PDF]

Journal of Clinical Microbiology
Macrolides are the first-line treatment for Mycoplasma pneumoniae infections; however, macrolide resistance has been reported. We evaluated the clinical performance of two commercial assays for detecting macrolide-resistant M.
Nadège Hénin, Alicia Silvant, Marie Gardette, Carla Balcon, Jennifer Guiraud, Cécile Bébéar, Sabine Pereyre   +6 more
doaj   +2 more sources

Antibiotic Potentiation as a Promising Strategy to Combat Macrolide Resistance in Bacterial Pathogens

Antibiotics, 2023
Antibiotics, which hit the market with astounding impact, were once called miracle drugs, as these were considered the ultimate cure for infectious diseases in the mid-20th century.
Deepjyoti Paul, Meenal Chawla, Taruna Ahrodia, Lekshmi Narendrakumar, Bhabatosh Das   +4 more
doaj   +3 more sources

Prevalence of macrolide resistance in Treponema pallidum is associated with macrolide consumption

Journal of Medical Microbiology, 2019
We hypothesized that the large global variations in the prevalence of macrolide resistance in Treponema pallidum are related to differences in population-level macrolide consumption. The hypothesis was tested by, at a country-level, regressing the peak prevalence of macrolide resistance against the national macrolide consumption in the year prior to ...
exaly   +3 more sources

Increase of Macrolide-Resistance in Streptococcus pneumoniae Strains After the Introduction of the 13-Valent Pneumococcal Conjugate Vaccine in Lima, Peru

Frontiers in Cellular and Infection Microbiology, 2022
Streptococcus pneumoniae upper respiratory infections and pneumonia are often treated with macrolides, but recently macrolide resistance is becoming an increasingly important problem. The 13-valent pneumococcal conjugate vaccine (PCV13) was introduced in
Brayan E. Gonzales, Erik H. Mercado, Maria Pinedo-Bardales, Noemi Hinostroza, Francisco Campos, Eduardo Chaparro, Eduardo Chaparro, Olguita Del Águila, María E. Castillo, María E. Castillo, Andrés Saenz, Isabel Reyes, Theresa J. Ochoa, Theresa J. Ochoa   +13 more
doaj   +1 more source

C. acnes qPCR-Based Antibiotics Resistance Assay (ACQUIRE) Reveals Widespread Macrolide Resistance in Acne Patients and Can Eliminate Macrolide Misuse in Acne Treatment

Frontiers in Public Health, 2022
BackgroundMacrolides have been widely used to treat moderate-to-severe acne for more than 50 years. However, the prevalent antibiotic resistance of Propionibacterium acnes, along with the absence of clinically available resistance tests, has made ...
Jingheng Zhang, Fang Yu, Keyun Fu, Xinyu Ma, Yi Han, Chi Ching Ali, Haonan Zhou, Yantao Xu, Yantao Xu, Tingyue Zhang, Shuntong Kang, Yiming Xu, Zhuolin Li, Jiaqi Shi, Shuai Gao, Yongyi Chen, Yongyi Chen, Liyu Chen, Jianglin Zhang, Jianglin Zhang, Jianglin Zhang, Feizhou Zhu, Feizhou Zhu, Feizhou Zhu   +23 more
doaj   +1 more source

The clinical significance of and the factors associated with macrolide resistance and poor macrolide response in pediatric Mycoplasma pneumoniae infection: A retrospective study

Journal of Microbiology, Immunology and Infection, 2023
Background: Macrolide-resistant Mycoplasma pneumoniae (MRMP) infection is increasing worldwide. However, its clinical significance is still uncertain.
Meng-Hsiu Yen, Dah-Chin Yan, Chao-Jan Wang, Kuo-Chien Tsao, Yi-Chuan Huang, Shao-wen Cheng, Cheng-Hsun Chiu, Yhu-Chering Huang, Tzou-Yien Lin   +8 more
doaj   +1 more source